跳至主要内容
临床试验/IRCT2015060722584N1
IRCT2015060722584N1已完成3 期

Comparison of the efficacy of Cuscuta Chinensis versus Fluoxetine on depression in cases with major depression

Shiraz university of medical science0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Inclusion: patients over 18 with the diagnosis of depression based on DSM5 and Beck criteria, patients with written informed consent.
  • Exclusion: Other underlying psychological disorder like Schizophrenia, schizoaffective, bipolar disorder, psychotic disorder, organic disorder make depression directly like hypothyroidism, pregnancy lactation, addiction, patients with suicidal thought and the patients. Who may need electronic convulsive therapy (ECT), being under the treatment of antidepressant on 1 month ago, chronic respiratory disease and past history of drug reaction to Cuscuta.

排除标准

  • 未提供

研究者

发起方
Shiraz university of medical science

相似试验